Centenial Surgical Suture
73.20
0.00(0.00%)
Market Cap₹26.70 Cr
PE Ratio-12.12
IndustryHealthcare
Company Performance:
1D0.00%
1M-18.05%
6M-29.48%
1Y-50.81%
5Y+37.34%
View Company Insightsright
More news about Centenial Surgical Suture
17Mar 26
Centenial Surgical Suture Ltd Alleges Price Manipulation in Response to BSE Surveillance Inquiry
Centenial Surgical Suture Ltd responded to BSE surveillance inquiry dated March 13, 2026, alleging systematic price manipulation through suspicious small-lot transactions by investors across India. The company provided detailed trading data from January-March 2026 and requested comprehensive investigation, emphasizing no material announcements justified the price movements and confirming management has no involvement in the alleged activities.
 no imag found
17Feb 26
Centenial Surgical Suture Files BSE Complaint Alleging Price Manipulation in Scrip 531308
Centenial Surgical Suture Ltd has filed a formal complaint with BSE alleging price manipulation in scrip 531308 during February 06-13, 2026. The company reported suspicious small-volume trading activities and requested investigation into potential SEBI regulation violations, while denying any involvement by company insiders in the alleged manipulative practices.
 no imag found
12Feb 26
Centenial Surgical Suture Ltd. Board Approves Q3FY26 Financial Results
Centenial Surgical Suture Ltd. board approved standalone unaudited financial results for the quarter and nine months ended December 31, 2025, during a 20-minute meeting on February 12, 2026. The approval was conducted in compliance with Regulation 33 of SEBI (LODR) Regulations, 2015, with proper regulatory disclosure made to BSE Limited.
 no imag found
10Oct 25
Centenial Surgical Suture Ltd Strengthens Audit Committee with New Appointment
Centenial Surgical Suture Ltd has appointed Neel Vora, an Independent Non-Executive Director, to its Audit Committee effective October 10, 2025. The appointment was made through a Circular Resolution passed by the Board of Directors. The reconstituted Audit Committee now comprises four members: Akash Modi (Chairman), Ridhima Limaye, Neel Vora, and Vijay Majrekar. This change aligns with the company's efforts to maintain high standards of financial oversight and transparency.
 no imag found
1 Year Returns:-50.81%
Industry Peers
Poly Medicure
1,650.20
(-0.04%)
Tarsons Products
259.03
(+0.30%)
Q-Line Biotech
546.50
(-5.15%)
Laxmi Dental
224.76
(+0.00%)
Osel Devices
465.80
(+3.32%)
Fabtech Technologies
156.92
(-0.49%)
Vasa Denticity
373.35
(+1.04%)
Prevest Denpro
378.55
(-1.29%)
Aprameya Engineering
151.00
(-1.15%)